Therapeutics
Cymbalta
Cymbalta is approved by the FDA for the treatment of major depressive disorder, as well as for the management of diabetic peripheral neuropathic pain (DPNP). It offers relief from both the emotional and painful physical symptoms associated with depression.
Scientific studies in the laboratory have shown that Cymbalta is a balanced and selective serotonin and norepinephrine reuptake inhibitor (SSNRI), and that it affects two naturally-occurring chemicals in the brain and in the spinal cord, serotonin and norepinephrine.
Research suggests that these chemicals play a role in depression and pain.
Cymbalta comes in a capsule and can be taken once a day. The target daily dose for Cymbalta is 60 mg. However, your doctor may prescribe a different dose based on his or her medical judgment. Cymbalta is available in 20 mg, 30 mg and 60 mg capsules. Cymbalta is not recommended for those under 18.
Lyrica
LYRICA was Developed for Diabetic Nerve Pain
LYRICA is an effective medicine approved by the FDA. It was developed to treat the nerve pain that can occur with diabetes. This kind of nerve pain is called Diabetic Nerve Pain. The medical name is Diabetic Peripheral Neuropathy (DPN)
Diabetic Nerve Pain is Different from Other Kinds of Pain
Diabetic Nerve Pain is the result of damage to your nerves. People with this disease who have high blood sugar levels over time often have Nerve Pain. The pain may feel like stabbing, tingling, or burning. It may cause unpleasant tingling and numbness as well.